Get started
Author

Mariella Di Marco

Observed names: M. Di Marco, Mariella Di Marco
ORCID: 0000-0002-4648-3365
Observed ORCID: 0000-0002-4648-3365
OpenAlex ID: A5068464587
Prognosis of untreated hepatocellular carcinoma
2014 · Edoardo G. Giannini, Fabio Farinati, et al. · Hepatology · 260
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
2014 · Alessandro Vitale, Patrizia Burra, et al. · Journal of Hepatology · 211
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
2021 · Alessandro Vitale, Gianluca Svegliati-Baroni, et al. · Gut · 194
PDF
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
2016 · Fabio Farinati, Alessandro Vitale, et al. · PLoS Medicine · 143
PDF
Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis
2014 · Paolo Del Poggio, Stefano Olmi, et al. · Clinical Gastroenterology and Hepatology · 137
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
2014 · Alessandro Cucchetti, Franco Trevisani, et al. · Journal of Hepatology · 123
Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use
2014 · Edoardo G. Giannini, Giorgio Sammito, et al. · Cancer · 72
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients
2013 · Edoardo G. Giannini, Vincenzo Savarino, et al. · Liver International · 52
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma
2025 · Alba Rocco, Costantino Sgamato, et al. · Hepatology International · 27
Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort
2020 · Alessandro Soria, Marco Fava, et al. · Liver International · 21
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
2023 · Nicola Reggidori, Laura Bucci, et al. · JHEP Reports · 20
PDF
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
2022 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 17
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
2019 · Roberta D’Ambrosio, Luisa Pasulo, et al. · Digestive and Liver Disease · 17
Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor
2015 · Alessandro Vitale, Fabio Farinati, et al. · Liver Transplantation · 14
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma
2024 · Edoardo G. Giannini, Andrea Pasta, et al. · Liver International · 11
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study
2021 · Giovanni Marasco, Francesco Poggioli, et al. · Cancers · 11
PDF
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
2021 · Giovanni Marasco, Antonio Colecchia, et al. · Digestive and Liver Disease · 11
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
2024 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 9
PDF
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison
2025 · Felice Giuliante, Simone Famularo, et al. · JHEP Reports · 6
Outcome of hepatic resection for HCC in ideal and non-ideal candidates
2025 · Lorenzo Lani, Laura Bucci, et al. · Hepatology Communications · 2
THU-180-Treatment of genotype 3 HCV infection in the large real-life “Navigatore Lombardia” multicentre cohort: Results from three different regimens
2019 · Alessandro Soria, Giuseppe Lapadula, et al. · Journal of Hepatology · 1
Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C
2019 · Stefano Fagiuoli, Luisa Pasulo, et al. · Farmeconomia Health economics and therapeutic pathways · 1
PDF
THU-128-Renal safety in 3,264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study
2019 · Roberta D’ambrosio, Luisa Pasulo, et al. · Journal of Hepatology
Health-economic evaluation of different organizational models to manage the Hepatitis C patient journey
2018 · S. Fagiuoli, L. Pasulo, et al. · Digestive and Liver Disease
Works count: 24
Citation count: 1,360
H-index: 14
I10-index: 17
Year
Topic
Type